These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2522477)

  • 1. Structural change in the rat hindlimb during deoxycorticosterone acetate hypertension; its reversibility and prevention.
    Vial JH; Yong AC; Boyd GW
    J Hypertens; 1989 Feb; 7(2):143-50. PubMed ID: 2522477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histometric assessment of renal arterioles during DOCA and post-DOCA hypertension and hydralazine treatment in rats.
    Vial JH; Boyd GW
    J Hypertens; 1989 Mar; 7(3):203-9. PubMed ID: 2708816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of structural arteriolar changes in DOCA hypertension with hydrallazine.
    Vial JH; Yong AC; Boyd GW
    Clin Exp Pharmacol Physiol; 1983; 10(3):335-9. PubMed ID: 6627749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural changes vary along individual arterioles in deoxycorticosterone acetate hypertensive rats.
    Vial JH; Yong AC; Walker MB; Boyd GW
    J Hypertens; 1989 Feb; 7(2):151-8. PubMed ID: 2926133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional changes in vascular resistance and reactivity in the deoxycorticosterone acetate (DOCA)-hypertensive pig.
    Berecek KH; Bohr DF
    Circ Res; 1977 May; 40(5 Suppl 1):I146-52. PubMed ID: 870224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset and offset of structural arteriolar changes in DOCA/salt hypertension in the rat.
    Vial JH; Yong AC; Boyd GW
    Clin Exp Pharmacol Physiol; 1982; 9(3):309-13. PubMed ID: 7140010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
    Silva AL; Cabral AM; Abreu GR; Pires JG; Bissoli NS; Ramage AG
    Eur J Pharmacol; 2005 Aug; 518(2-3):152-7. PubMed ID: 16014306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
    Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium prevents saline deoxycorticosterone acetate (DOCA) hypertension in the rat.
    Iaina A; Shochat J; Serban I; Kapuler S; Gavendo S; Goldfarb D; Eliahou HE
    J Lab Clin Med; 1982 Feb; 99(2):231-8. PubMed ID: 6278037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hypertension and cardiac hypertrophy in guinea pig by DOCA salt.
    Tiritilli A; Ruff F
    Methods Find Exp Clin Pharmacol; 1994; 16(6):391-6. PubMed ID: 7837830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
    Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary vascular function and morphology in hydralazine treated DOCA salt rats.
    Anderson PG; Bishop SP; Digerness SB
    J Mol Cell Cardiol; 1988 Oct; 20(10):955-67. PubMed ID: 2975341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Takaoka M; Ohkita M; Itoh M; Kobayashi Y; Okamoto H; Matsumura Y
    Clin Exp Pharmacol Physiol; 2001; 28(5-6):466-8. PubMed ID: 11380524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats.
    Wang DS; Xie HH; Shen FM; Cai GJ; Su DF
    Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):545-52. PubMed ID: 16026514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
    Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antihypertensive effect of taurine in DOCA-salt rats.
    Fujita T; Sato Y
    J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase.
    Jiménez R; López-Sepúlveda R; Kadmiri M; Romero M; Vera R; Sánchez M; Vargas F; O'Valle F; Zarzuelo A; Dueñas M; Santos-Buelga C; Duarte J
    Free Radic Biol Med; 2007 Aug; 43(3):462-73. PubMed ID: 17602962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M; Martin A; Liu DT; Whitworth JA
    J Hypertens; 1994 May; 12(5):569-76. PubMed ID: 7930557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.